New Delhi, February 12 Zydus Lifesciences announced on Thursday that it will pay USD 120 million to Astellas Pharma to settle a patent dispute over a medication for treating an overactive bladder.Zydus Pharmaceuticals USA, Inc, a wholly-owned subsidiary of the company, has entered into a...
New Delhi, February 11 The Supreme Court on Wednesday refused to restrain Zydus Lifesciences from selling its affordable, generic biosimilar of Nivolumab, a life-saving cancer drug registered by Bristol Myers Squibb (BMS).A bench of Chief Justice Surya Kant and Justice Joymalya Bagchi was...
New Delhi, February 9 Zydus Lifesciences Ltd on Monday reported a 1.81 per cent increase in consolidated net profit at Rs 1,042.1 crore for the quarter ended December 31, 2025.The company had posted a consolidated net profit of Rs 1,023.5 crore in the corresponding quarter of the previous...